However, observed atherosclerosis related DNA hypermethylation trend for most BRCA1 and CRISP2 CpG probes does not follow the expected methylation change in blood samples enriched for granulocyte and reduced CD8+ T immune cell subpopulations. This evidence concerns the gene CRISP2 and atherosclerosis.